Target intelligence / Profile preview

Sodium channel protein type 9 subunit alpha (Nav1.7), Sodium channel protein type 10 subunit alpha (Nav1.8), and Sodium channel protein type 5 subunit alpha (Nav1.5) (Nav1.7/Nav1.8/Nav1.5)

Target
Nav1.7/Nav1.8/Nav1.5
Molecular classification
Ion channel, Voltage-gated ion channel, Sodium channel, Transmembrane protein
01

Overview

Voltage-gated sodium channels (VGSCs) are essential transmembrane proteins that facilitate the rapid influx of sodium ions, driving the depolarization phase of action potentials in excitable tissues. This specific group comprises Nav1.7, Nav1.8, and Nav1.5, which are distinguished by their unique tissue distribution and physiological roles. Nav1.7 and Nav1.8 are primarily localized in the peripheral sensory neurons of the dorsal root ganglia, where they act as critical gatekeepers for pain signaling and nociception [UniProt Q15858, Q9Y5Y9]. In contrast, Nav1.5 is the predominant isoform in cardiac myocytes, essential for maintaining normal heart rhythm and electrical conduction [UniProt Q14524]. Therapeutic interest in Nav1.7 and Nav1.8 has surged due to their potential as targets for novel non-opioid analgesics, particularly for treating neuropathic and inflammatory pain [PubMed PMC6135004]. However, a major challenge in developing these analgesics is achieving high selectivity to avoid cross-reactivity with Nav1.5, which can cause life-threatening cardiotoxicity, or with CNS-resident channels that cause neurological impairment [StatPearls NBK540971]. Drugs like lidocaine act as non-selective blockers for anesthesia, while newer agents like suzetrigine (VX-548) are designed to target Nav1.8 with high specificity to improve safety [NEJM 2024]. Understanding the structural differences between these isoforms is vital for the design of precision medicines that manage pain without compromising cardiac or central nervous system function.

Other names
SCN9ASCN10ASCN5AVoltage-gated sodium channel alpha subunitPeripheral nerve sodium channel 1 (PN1)Peripheral nerve sodium channel 3 (PN3)Cardiac sodium channel alpha subunitSkM2H1
02

Mechanism of action

Inhibition of the alpha-subunit pore to prevent sodium ion influx, thereby suppressing membrane depolarization and action potential generation in neurons or myocytes [PubChem, StatPearls NBK540971].

03

Biological functions

Action potential initiationAction potential propagationSensory transductionCardiac conductionNociceptionSodium ion transport
04

Disease associations

Neuropathic painChronic painCardiac arrhythmiaBrugada syndromeLong QT syndrome type 3ErythromelalgiaCongenital insensitivity to painSmall fiber neuropathyParoxysmal extreme pain disorder
05

Safety considerations

Cardiotoxicity (arrhythmias, heart block) due to off-target Nav1.5 inhibitionCentral nervous system side effects (dizziness, ataxia, seizures) due to off-target activity on Nav1.1, Nav1.2, or Nav1.6Narrow therapeutic index for non-selective blockersPotential for hypotensionPro-arrhythmic effects in patients with underlying structural heart disease
06

Interacting drugs

Suzetrigine (VX-548)

11 more in the full profile.

07

Biomarkers

SCN9A genetic mutationsSCN10A genetic mutationsSCN5A genetic mutationsNerve conduction velocityElectrocardiogram (ECG) PR intervalQRS durationQT interval

Beyond the preview

Go deeper on Sodium channel protein type 9 subunit alpha (Nav1.7), Sodium channel protein type 10 subunit alpha (Nav1.8), and Sodium channel protein type 5 subunit alpha (Nav1.5) (Nav1.7/Nav1.8/Nav1.5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium channel protein type 9 subunit alpha (Nav1.7), Sodium channel protein type 10 subunit alpha (Nav1.8), and Sodium channel protein type 5 subunit alpha (Nav1.5) (Nav1.7/Nav1.8/Nav1.5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call